Neil Kumar
CEO and President at BridgeBio Pharma Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Maze Therapeutics Inc. June 8, 202681.6%
-
BridgeBio Oncology Therapeutics Inc. August 4, 2025100.0%
-
BridgeBio Pharma Inc. June 20, 202598.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | BridgeBio Pharma Inc. | Open-market sale | −8,721 | $69.01 | $601,836 |
| Sep 17, 2026 | BridgeBio Pharma Inc. | Open-market sale | −1,279 | $69.57 | $88,980 |
| Aug 19, 2026 | BridgeBio Pharma Inc. | Open-market sale | −8,100 | $83.86 | $679,266 |
| Aug 19, 2026 | BridgeBio Pharma Inc. | Open-market sale | −1,800 | $84.69 | $152,442 |
| Aug 19, 2026 | BridgeBio Pharma Inc. | Open-market sale | −100 | $85.65 | $8,565 |
| Aug 18, 2026 | BridgeBio Pharma Inc. | Open-market sale | −1,900 | $81.15 | $154,185 |
| Aug 18, 2026 | BridgeBio Pharma Inc. | Open-market sale | −17,279 | $82.21 | $1,420,507 |
| Aug 18, 2026 | BridgeBio Pharma Inc. | Open-market sale | −14,602 | $82.99 | $1,211,820 |
| Aug 18, 2026 | BridgeBio Pharma Inc. | Open-market sale | −1,199 | $83.77 | $100,440 |
| Aug 16, 2026 | BridgeBio Pharma Inc. | Option exercise | +33,544 | — | — |
| Aug 16, 2026 | BridgeBio Pharma Inc. | Option exercise | +19,599 | — | — |
| Aug 16, 2026 | BridgeBio Pharma Inc. | Option exercise | +11,554 | — | — |
| Aug 16, 2026 | BridgeBio Pharma Inc. | Option exercise | +6,520 | — | — |
| Aug 16, 2026 | BridgeBio Pharma Inc. | Shares withheld for tax | −36,237 | $79.86 | $2,893,887 |
| Jun 5, 2026 | BridgeBio Pharma Inc. | Open-market sale | −7,147 | $67.20 | $480,278 |
Questions about Neil Kumar
What boards is Neil Kumar on?
Neil Kumar sits on the boards of BridgeBio Oncology Therapeutics Inc., BridgeBio Pharma Inc. and Maze Therapeutics Inc.
What company is Neil Kumar the CEO of?
Neil Kumar is CEO and President of BridgeBio Pharma Inc.
How long has Neil Kumar served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.